Oxaliplatin
Categorie
Oxaliplatin Les marques, Oxaliplatin Analogs
Oxaliplatin Les marques melange
Oxaliplatin Formule chimique
Oxaliplatin RX lien
Oxaliplatin FDA fiche
Oxaliplatin msds (fiche de securite des materiaux)
Oxaliplatin Synthese de reference
Oxaliplatin Poids moleculaire
Oxaliplatin Point de fusion
Oxaliplatin H2O Solubilite
Oxaliplatin Etat
Oxaliplatin LogP
Oxaliplatin Formes pharmaceutiques
Oxaliplatin Indication
Oxaliplatin Pharmacologie
Oxaliplatin Absorption
Oxaliplatin Toxicite
Oxaliplatin Information pour les patients
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
